Literature DB >> 32631525

Synthesis and dopamine receptor pharmacological evaluations on ring C ortho halogenated 1-phenylbenzazepines.

Rajan Giri1, Hari K Namballa2, Ananta Sarker2, Ian Alberts3, Wayne W Harding4.   

Abstract

A series of 1-phenylbenzazepines containing bromine or chlorine substituents at the ortho position of the appended phenyl ring (2'-monosubstituted or 2',6'- disubstituted patterns) were synthesized and evaluated for affinity towards dopamine D1R, D2R and D5R. As is typical of the 1-phenylbenzazepine scaffold, the compounds displayed selectivity towards D1R and D5R; analogs generally lacked affinity for D2R. Interestingly, 2',6'-dichloro substituted analogs showed modest D5R versus D1R selectivity whereas this selectivity was reversed in compounds with a 2'-halo substitution pattern. Compound 10a was identified as a D1R antagonist (Ki = 14 nM; IC50 = 9.4 nM).
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Benzazepine; D1; D2; D5; Dopamine

Mesh:

Substances:

Year:  2020        PMID: 32631525      PMCID: PMC7340849          DOI: 10.1016/j.bmcl.2020.127305

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  37 in total

1.  High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.

Authors:  Vadim Cherezov; Daniel M Rosenbaum; Michael A Hanson; Søren G F Rasmussen; Foon Sun Thian; Tong Sun Kobilka; Hee-Jung Choi; Peter Kuhn; William I Weis; Brian K Kobilka; Raymond C Stevens
Journal:  Science       Date:  2007-10-25       Impact factor: 47.728

Review 2.  Advances in Dopamine D1 Receptor Ligands for Neurotherapeutics.

Authors:  Daniel E Felsing; Manish K Jain; John A Allen
Journal:  Curr Top Med Chem       Date:  2019       Impact factor: 3.295

Review 3.  Dopamine and addiction: what have we learned from 40 years of research.

Authors:  Marcello Solinas; Pauline Belujon; Pierre Olivier Fernagut; Mohamed Jaber; Nathalie Thiriet
Journal:  J Neural Transm (Vienna)       Date:  2018-12-19       Impact factor: 3.575

4.  Dopamine D1/D5 receptor antagonists with improved pharmacokinetics: design, synthesis, and biological evaluation of phenol bioisosteric analogues of benzazepine D1/D5 antagonists.

Authors:  Wen-Lian Wu; Duane A Burnett; Richard Spring; William J Greenlee; Michelle Smith; Leonard Favreau; Ahmad Fawzi; Hongtao Zhang; Jean E Lachowicz
Journal:  J Med Chem       Date:  2005-02-10       Impact factor: 7.446

Review 5.  Fenoldopam: a review of its pharmacodynamic and pharmacokinetic properties and intravenous clinical potential in the management of hypertensive urgencies and emergencies.

Authors:  R N Brogden; A Markham
Journal:  Drugs       Date:  1997-10       Impact factor: 9.546

6.  Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines.

Authors:  F R Pfeiffer; J W Wilson; J Weinstock; G Y Kuo; P A Chambers; K G Holden; R A Hahn; J R Wardell; A J Tobia; P E Setler; H M Sarau
Journal:  J Med Chem       Date:  1982-04       Impact factor: 7.446

7.  Exploring the structure-activity relationship of the ethylamine portion of 3-iodothyronamine for rat and mouse trace amine-associated receptor 1.

Authors:  Edwin S Tan; Motonori Miyakawa; James R Bunzow; David K Grandy; Thomas S Scanlan
Journal:  J Med Chem       Date:  2007-05-12       Impact factor: 7.446

8.  (+/-)-3-allyl-7-halo-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines as selective high affinity D1 dopamine receptor antagonists: synthesis and structure-activity relationship.

Authors:  N Baindur; M Tran; H B Niznik; H C Guan; P Seeman; J L Neumeyer
Journal:  J Med Chem       Date:  1992-01       Impact factor: 7.446

9.  Synthesis of 6-substituted 1-phenylbenzazepines and their dopamine D(1) receptor activities.

Authors:  Jing Zhang; Xuetao Chen; Leiping Yu; Xuechu Zhen; Ao Zhang
Journal:  Bioorg Med Chem       Date:  2008-09-20       Impact factor: 3.641

10.  Pharmacological evaluation of SCH-12679: evidence for an in vivo antagonism of D1-dopamine receptors.

Authors:  G R Breese; H E Criswell; R D McQuade; L C Iorio; R A Mueller
Journal:  J Pharmacol Exp Ther       Date:  1990-02       Impact factor: 4.030

View more
  2 in total

1.  Synthesis of Chiral Tetrahydro-3-benzazepine Motifs by Iridium-Catalyzed Asymmetric Hydrogenation of Cyclic Ene-carbamates.

Authors:  Bram B C Peters; Pher G Andersson; Somsak Ruchirawat; Winai Ieawsuwan
Journal:  Org Lett       Date:  2022-03-03       Impact factor: 6.005

2.  The Signaling and Pharmacology of the Dopamine D1 Receptor.

Authors:  Jace Jones-Tabah; Hanan Mohammad; Emma G Paulus; Paul B S Clarke; Terence E Hébert
Journal:  Front Cell Neurosci       Date:  2022-01-17       Impact factor: 5.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.